RVPH
Price
$0.44
Change
-$0.01 (-2.22%)
Updated
Sep 5 closing price
Capitalization
29.85M
70 days until earnings call
VRAX
Price
$0.56
Change
-$0.05 (-8.20%)
Updated
Sep 5 closing price
Capitalization
2.45M
Interact to see
Advertisement

RVPH vs VRAX

Header iconRVPH vs VRAX Comparison
Open Charts RVPH vs VRAXBanner chart's image
Reviva Pharmaceuticals Holdings
Price$0.44
Change-$0.01 (-2.22%)
Volume$626.46K
Capitalization29.85M
Virax Biolabs Group
Price$0.56
Change-$0.05 (-8.20%)
Volume$925.18K
Capitalization2.45M
RVPH vs VRAX Comparison Chart in %
Loading...
RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RVPH vs. VRAX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RVPH is a StrongBuy and VRAX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (RVPH: $0.44 vs. VRAX: $0.56)
Brand notoriety: RVPH and VRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RVPH: 25% vs. VRAX: 137%
Market capitalization -- RVPH: $29.85M vs. VRAX: $2.45M
RVPH [@Biotechnology] is valued at $29.85M. VRAX’s [@Biotechnology] market capitalization is $2.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RVPH’s FA Score shows that 1 FA rating(s) are green whileVRAX’s FA Score has 0 green FA rating(s).

  • RVPH’s FA Score: 1 green, 4 red.
  • VRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, RVPH is a better buy in the long-term than VRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RVPH’s TA Score shows that 4 TA indicator(s) are bullish while VRAX’s TA Score has 4 bullish TA indicator(s).

  • RVPH’s TA Score: 4 bullish, 5 bearish.
  • VRAX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both RVPH and VRAX are a bad buy in the short-term.

Price Growth

RVPH (@Biotechnology) experienced а -2.44% price change this week, while VRAX (@Biotechnology) price change was -6.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

RVPH is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVPH($29.9M) has a higher market cap than VRAX($2.45M). VRAX (-74.889) and RVPH (-75.746) have similar YTD gains . VRAX has higher annual earnings (EBITDA): -6.43M vs. RVPH (-27.07M). RVPH has more cash in the bank: 10.4M vs. VRAX (7.29M). RVPH has less debt than VRAX: RVPH (113K) vs VRAX (380K). VRAX has higher revenues than RVPH: VRAX (84.9K) vs RVPH (0).
RVPHVRAXRVPH / VRAX
Capitalization29.9M2.45M1,219%
EBITDA-27.07M-6.43M421%
Gain YTD-75.746-74.889101%
P/E RatioN/AN/A-
Revenue084.9K-
Total Cash10.4M7.29M143%
Total Debt113K380K30%
FUNDAMENTALS RATINGS
RVPH: Fundamental Ratings
RVPH
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
11
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RVPHVRAX
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BILL51.544.85
+10.39%
BILL Holdings
DARE2.150.02
+0.94%
Dare Bioscience Inc.
AJG299.18-0.39
-0.13%
Arthur J Gallagher & Co
NETD11.29-0.02
-0.18%
Nabors Energy Transition Corp
YEXT8.95-0.11
-1.21%
Yext

RVPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVPH has been loosely correlated with ALT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if RVPH jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVPH
1D Price
Change %
RVPH100%
-1.75%
ALT - RVPH
40%
Loosely correlated
+6.18%
GYRE - RVPH
31%
Poorly correlated
+1.45%
INDP - RVPH
30%
Poorly correlated
-28.35%
VRAX - RVPH
28%
Poorly correlated
-6.87%
INM - RVPH
27%
Poorly correlated
+0.96%
More

VRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRAX has been loosely correlated with ALZN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VRAX jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRAX
1D Price
Change %
VRAX100%
-6.87%
ALZN - VRAX
45%
Loosely correlated
+2.20%
REVB - VRAX
31%
Poorly correlated
+2.50%
RVPH - VRAX
28%
Poorly correlated
-1.75%
BVNKF - VRAX
27%
Poorly correlated
N/A
AURX - VRAX
27%
Poorly correlated
-2.73%
More